HCM
AMPE

Highbridge Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Highbridge Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-79
Closed -$83K – 1514
2014
Q3 		$83K Buy
+79
New +$133K ﹤0.01% 1151
2014
Q2 		– Sell
-106
Closed -$202K – 1345
2014
Q1 		$202K Buy
+106
New +$251K ﹤0.01% 966

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highbridge Capital Management's AMPE Position: Q4 2014 in Review

Highbridge Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 79 shares — an estimated $83K sold.

Highbridge Capital Management first reported a position in AMPE in Q1 2014 and held it in 2 quarters. The position peaked at $202K in Q1 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • Highbridge Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Highbridge Capital Management sold 79 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $83K.
  • Highbridge Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 2 quarters.
  • Highbridge Capital Management's Ampio Pharmaceuticals Inc. position peaked at $202K in Q1 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on Highbridge Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.